As of Jun 09
| -6.21 / -2.66%|
The 20 analysts offering 12-month price forecasts for Karuna Therapeutics Inc have a median target of 272.00, with a high estimate of 334.00 and a low estimate of 193.00. The median estimate represents a +19.50% increase from the last price of 227.61.
The current consensus among 21 polled investment analysts is to Buy stock in Karuna Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.